Home / Posts Tagged "Dr. Krishna Prasad Chigurupati"

Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Capsules in strengths

READ MORE

Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter ended December 31, 2024. Financial Summary (All numbers in INR Mn., except Margins)   QUARTERLY CONSOLIDATED FINANCIALS Q3FY25 Q2FY25 Growth (QoQ) Q3FY24 Growth (YoY) Revenue from Operations 11,377 9,666 18% 11,556 -2% EBITDA 2,303 2,033 13% 2,505 -8% EBITDA % 20% 21%   22%   PAT 1,176 972 21% 1,257 -6% PAT % 10% 10%   11%     Financial and Business Summary for Q3FY25 The Company voluntarily paused

READ MORE

Mumbai, December 17, 2024 – Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine

READ MORE

Granules' Ambitious Climate Targets Span Near-Term, Long-Term, and Net-Zero Goals, Aligned with the 1.5°C Pathway Granules India Limited, a leading global pharmaceutical company, has received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term, and net-zero goals. These targets, aligned with the

READ MORE

Granules India Limited, a leading pharmaceutical company, is thrilled to announce that it has received the Golden Peacock Award for Sustainability. This esteemed award was presented at the Institute of Directors’ Annual Global Convention on Corporate Governance & Sustainability being held in London, UK, and

READ MORE

Granules India inaugurated and launched its packaging facility through its Granules Consumer Health (GCH) step-down subsidiary which is located in Manassas, Virginia, US. The facility is over 79,000 square feet and is equipped with packaging lines and clean rooms to package and ship prescription and

READ MORE